Prof. Regina Barzilay’s research group is working with MGH to use artificial intelligence and machine learning to improve cancer diagnoses, reports CNBC’s Meg Tirrell. The group also hopes to allow doctors to use “the huge quantities of data available on patients to make more personalized treatment decisions,” explains Tirrell.
Boston Herald reporter Lindsay Kalter writes that Prof. Ed Boyden is working on a new effort to develop technologies that would allow doctors to explore tumors using virtual reality. Boyden explains that he and his colleagues hope to use virtual reality to explore “what a tumor’s weaknesses are, and what makes it thrive.”
Prof. Bob Weinberg of the Whitehead Institute spoke with Karen Weintraub at WBUR about the best ways to prevent cancer. Reducing obesity and smoking will lead to “decreases in cancer mortality, at least over the next decade or two, that dwarf anything I and my colleagues can produce in terms of new, miraculous cures,” he said.
Prof. Tyler Jacks, director of the Koch Institute, speaks with Meghna Chakrabarti of WBUR’s Radio Boston about cancer research in Boston. Jacks says the large number of researchers in the area “gives us a distinctive advantage,” as it provides researchers the opportunity to interact and collaborate with various institutions.
Boston Globe reporter Priyanka Dayal McCluskey writes that researchers from the Broad Institute and IBM are joining forces to examine why many cancer patients become resistant to drugs. The researchers hope this new effort could “help doctors prescribe more effective combinations of drugs for cancer patients.”
MIT researchers have developed a new technique to stop the spread of cancer cells through the body by delivering microRNAs to the site of the primary tumor, reports Hallie Smith for Boston Magazine. The technique “may correct gene disruptions that put a patient at risk of metastatic cancer,” Smith explains.
Boston Magazine reporter Dana Guth writes that MIT researchers are programming harmless strains of E. coli bacteria to destroy tumor cells. Guth explains that the programmed bacteria could be ingested or injected and “could offer a new way to stave off liver cancer.”
Prof. Susan Lindquist has been named a recipient of the Albany Medical Center Prize in Medicine and Biomedical Research, according to the AP. Lindquist’s research has raised hopes that “treatments could prevent protein ‘misfolding’ that drives degenerative conditions like Alzheimer's, Parkinson's and Lou Gehrig's disease.”
MIT researchers have developed a programmable vaccine that could be used to respond to disease outbreaks, reports Ben Gruber for Reuters. The vaccine harnesses “messenger RNA, a genetic material that can be programmed to fight any viral, bacterial or parasitic disease by provoking an amplified immune response.”
An image created by researchers at the Koch Institute that shows red nanoparticles carrying MicroRNAs to an aggressive breast tumor is featured in the National Cancer Institute Cancer Close Up project. Washington Post reporter Laurie McGinley explains that the photographs are intended to spark public interest and encourage young people to consider a career in microbiology.
In an article for the Financial Times, Laura Noonan highlights Prof. Andrew Lo’s work investigating how the theories of financial engineering could be used to fight cancer. “In cancer drug development, because the risks of failure are so high, the probability of success goes up quite dramatically if you create a portfolio,” says Lo.
A team of MIT researchers has been selected as the winner of the Koch Institute research-grant pitch competition for their work on developing a diagnostic platform for early-stage leukemia, reports Amanda Hoover for Boston.com. Hoover explains that the diagnostic method would “single out individual cells during blood tests, highlighting those affected by leukemia.”
Washington Post reporter Laurie McGinley writes that Prof. Tyler Jacks, director of the Koch Institute for Integrative Cancer Research, was named to a panel of experts that will advise the Obama administration on the cancer “moonshot” initiative and how to best “tackle some of the most promising but challenging areas in research today.”
MIT researchers have found evidence that there may be windows of opportunity during which drugs are more effective at treating cancer, reports Ariana Eunjung Cha for The Washington Post. "If we know the route to resistance," explains Prof. Michael Hemann, "we can ambush tumor cells."
MIT researchers have uncovered a potential link between a high-fat diet and increased risk of many types of cancer, reports Chukwuma Muanya for The Guardian. Muanya explains that the study “reveals the effect that a high-fat diet has on the biology of stem cells… and how this might make cancer more likely.”